Invention Grant
US08975410B2 Crystal forms of 5-[3-(2,5-dichloro-4, 6-dimethyl-1-oxy-pyridine-3-yl)[1,2,4] oxadiazol-5-yl]-3-nitrobenzene-1,2-diol
有权
5- [3-(2,5-二氯-4,6-二甲基-1-氧 - 吡啶-3-基)[1,2,4]恶二唑-5-基] -3-硝基苯-1 ,2-二醇
- Patent Title: Crystal forms of 5-[3-(2,5-dichloro-4, 6-dimethyl-1-oxy-pyridine-3-yl)[1,2,4] oxadiazol-5-yl]-3-nitrobenzene-1,2-diol
- Patent Title (中): 5- [3-(2,5-二氯-4,6-二甲基-1-氧 - 吡啶-3-基)[1,2,4]恶二唑-5-基] -3-硝基苯-1 ,2-二醇
-
Application No.: US12933044Application Date: 2009-03-16
-
Publication No.: US08975410B2Publication Date: 2015-03-10
- Inventor: David Alexander Learmonth , Keith Lorimer , Kevin Wayne Meyer , Tibor Eszenyi , Álmosné Kovách
- Applicant: David Alexander Learmonth , Keith Lorimer , Kevin Wayne Meyer , Tibor Eszenyi , Álmosné Kovách
- Applicant Address: PT
- Assignee: BIAL—Portela & CA., S.A.
- Current Assignee: BIAL—Portela & CA., S.A.
- Current Assignee Address: PT
- Agency: The Marbury Law Group, PLLC
- International Application: PCT/PT2009/000013 WO 20090316
- International Announcement: WO2009/116882 WO 20090924
- Main IPC: C07D413/04
- IPC: C07D413/04
![Crystal forms of 5-[3-(2,5-dichloro-4, 6-dimethyl-1-oxy-pyridine-3-yl)[1,2,4] oxadiazol-5-yl]-3-nitrobenzene-1,2-diol](/abs-image/US/2015/03/10/US08975410B2/abs.jpg.150x150.jpg)
Abstract:
This invention relates to novel polymorphs of (HO)2NO2(C6H)—(C2N2O)—(C5N)(CH3)2Cl2O, to processes for their preparation, and to pharmaceutical compositions containing said novel polymorphs as active pharmaceutical ingredient.
Public/Granted literature
Information query